TransMedics Group Inc. (TMDX)
NASDAQ: TMDX
· Real-Time Price · USD
116.86
0.79 (0.68%)
At close: Oct 03, 2025, 2:27 PM
0.68% (1D)
| Bid | 116.7 |
| Market Cap | 3.98B |
| Revenue (ttm) | 531.29M |
| Net Income (ttm) | 71.66M |
| EPS (ttm) | 1.98 |
| PE Ratio (ttm) | 59.02 |
| Forward PE | 40.89 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 116.87 |
| Volume | 521,780 |
| Avg. Volume (20D) | 1,075,571 |
| Open | 115.86 |
| Previous Close | 116.07 |
| Day's Range | 115.10 - 119.78 |
| 52-Week Range | 55.00 - 146.98 |
| Beta | 2.17 |
| Ex-Dividend Date | n/a |
About TMDX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol TMDX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for TMDX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsTransMedics Group Inc. is scheduled to release its earnings on
Oct 27, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+11.14%
TransMedics shares are trading higher following a ...
Unlock content with
Pro Subscription
2 months ago
+6.59%
TransMedics Group shares are trading higher after the company announced it has been granted FDA IDE conditional approval.
